Search PubMed⌕ Search

Biomedical subjects

R B Douglas

Publications and source records attributed to R B Douglas.

16 recordsLinked to original sources

Organosilicon dental composite restoratives based on 1,3-bis[(p-acryloxymethyl) phenethyl] tetramethyldisiloxane.

OBJECTIVES: The major concern associated with the use of polysiloxanes as polymer matrices in dental restorative materials, is the generally modest mechanical properties of the polymers. However, it has long been demonstrated that thermal stability, and mechanical properties of polysiloxanes can be substantially modified by incorporation of bulkier substituents such as phenyl groups or more polar groups in the chains. The purpose of this research was to evaluate visible light activated dental composites based on the high molecular weight siloxane monomer 1,3-bis[(p-acryloxymethyl) phenethyl] tetramethyldisiloxane (BAPD). METHODS: Hardness, diametral tensile strength (DTS), degree of conversion (DC), water sorption (WS) and polymerization shrinkage of BAPD-based composites and bis-GMA-based composites were determined and compared. RESULTS: Composites based on BAPD exhibited low WS, high DC, low polymerization shrinkage, and had hardness and DTS values that were not significantly lower than those of dental composites based on bis-GMA. SIGNIFICANCE: BAPD is a high molecular weight monomer (MW = 511) with a low viscosity. It did not require the use of low molecular weight diluent monomers in formulating composite resins. The DC of BAPD was high, ranging from 86 to 94%. Although the DC of BAPD was significantly higher than the conventional difunctional dental monomers, the polymerization shrinkage of the siloxane composites (1.70 - 1.81 vol%) was comparable to several composites based on bis-GMA.

Absorption↗

Pulmonary function of London firemen.

In a longitudinal study of a sample of firemen in London 1006 firemen were interviewed and examined in 1976 and 895 were seen a second time 12 months later. On each occasion a Medical Research Council respiratory questionnaire was administered and forced expiratory volume in one second (FEV1) and forced vital capacity (FVC) were measured. The average levels of FEV1, FVC, and FEV1/FVC in both years compared favourably with conventional predicted values. Separate multiple regression analysis for the two years indicated that the FEV1 and FVC fell more rapidly in those aged over 40, and that cigarette smoking had a strong harmful effect on these measures of function. Only among men with over 20 years' service was there possibly any evidence (not statistically significant) of an effect from duration of employment. The comparatively large fall in FEV1 and FVC from 1976 to 1977 was due mainly to instrumental variation. The prevalence of respiratory symptoms was higher in smokers than non-smokers and increased with the number of cigarettes smoked.

Adolescent↗

Ipratropium bromide: mucociliary clearance rate and airway resistance in normal subjects.

The effect of ipratropium bromide, a new anticholinergic drug, on the rate of clearance of secretions from the lung and on airways resistance was investigated in 12 healthy subjects in a double-blind cross-over trial with placebo and a control run without aerosol. Before taking the drug the subjects inhaled uniform 5 micrometer tracer particles of polystyrene in which 99mTc had been unleachably incorporated. The initial depth of deposition and the rate of clearance of the particles were obtained from serial gamma counts made externally to the chest over six hours. The difference between drug, placebo and control runs in the deposition patterns of the tracer particles and their subsequent rates of clearance were not significant. The drug treatment resulted in statistically significant falls in specific airway resistance at 1, 2, 3 and 6 hours (P less than 0.02). There was no objective or subjective evidence of side effects from the drug.

Aerosol Propellants↗